Curanex Pharmaceuticals Inc (CURX)
$4.88+0.00%Close
BUYRECOVERY · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $138M
- Short % float
- 0.04%
- Days to cover
- 1.0
- SI change
- +9.3%
- 1W
- -2.20%
- 1M
- +8.69%
- vs SPY 1W
- -2.07%
- vs SPY 1M
- +6.18%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on CURX?
- LOPJLB’s latest quantitative signal on Curanex Pharmaceuticals Inc Common Stock (CURX) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is CURX in?
- Curanex Pharmaceuticals Inc Common Stock (CURX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Curanex Pharmaceuticals Inc Common Stock (CURX) do?
- Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoho…